Chapter 10. Lung and Respiratory Tract. Flashcards

1
Q

Acute respiratory distress syndrome (ARDS)

A

A disorder in which damage to alveoli throughout the lungs causes edema and leads to respiratory failure. Referred to clinically as “acute lung injury.”

Affects approximately 190,000 patients per year in the United States.

Characterized by rapid onset of life-threatening respiratory insufficiency, cyanosis. and severe arterial hypoxemia.

It may occur in association with primary pulmonary diseases or systemic inflammatory disorders.

The histologic manifestation is diffuse alveolar damage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Alveolus (pl., alveoli)

A

Any of the many tiny air sacs of the lungs which allow for rapid gaseous exchange.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Edema

A

An abnormal excess accumulation of serous fluid in connective tissue or in a serous cavity. Also called “dropsy.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cyanosis

A

A bluish discoloration of the skin resulting from poor circulation or inadequate oxygenation of the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Hypoxemia

A

An abnormally low concentration of oxygen in the blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Serous fluid (i.e., from the serum)

A

Of, resembling, or producing serum. A clear to pale yellow watery fluid that is found in the body especially in the spaces between organs and the membranes which line or enclose them (such as the heart and pericardium or abdomen and peritoneum) and that when occurring in large quantities is indicative of a pathological condition (such as cirrhosis or heart failure) or surgical complication.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aspiration

A

A condition in which food, liquids, saliva, or vomit is breathed into the airways.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hemorrhage

A

The release of blood from a broken blood vessel, either inside or outside the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hyaline membranes

A

Consist of fibrin-rich edema fluid mixed with debris from necrotic epithelial cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Obstructive (airway) disease

A

A chronic disease that decreases pulmonary gas exchange and that is characterized by an increase in resistance to air flow caused by partial or complete airway obstruction at any level.

In obstructive diseases, the forced vital capacity (FVC) is normal or slightly decreased, whereas the expiratory flow rate, usually measured as the forced expiratory volume at 1 second (FEV1), is significantly decreased. Thus, the ratio of FEV to FVC is decreased.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Restrictive disease

A

A chronic disease that decreases pulmonary gas exchange and that is characterized by reduced expansion of the lung parenchyma and decreased total lung capacity.

The forced vital capacity (FVC) is reduced and the expiratory flow rate is normal or reduced proportionately. Hence, the ratio of FEV to FVC is near normal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Forced vital capacity (FVC)

A

The total volume of air that can be forcibly expired after a maximal inspiration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Forced expiratory volume at 1 second (FEV1)

A

The volume of air that can be forcibly expired in the first second.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Expiratory flow rate

A

Usually measured as the forced expiratory volume at 1 second (FEV1).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the three major obstructive lung disorders?

A

Emphysema, chronic bronchitis, and asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Chronic obstructive pulmonary disease (COPD)

A

Characterized by obstructive airway and alveolar abnormalities caused by inhalation of noxious particles or gases, most often due to smoking tobacco.

Affects more than 5% of the adults in the United States, where it is the third leading cause of death, exceeded only by cardiovascular disease and cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Chronic bronchitis

A

A chronic obstructive pulmonary disease (COPD) that is a mechanical obstruction of the airways by mucus secretions and fibrosis.

Defined by the presence of a persistent productive cough for at least three consecutive months in at least two consecutive years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Emphysema

A

A chronic obstructive pulmonary disease (COPD) that is a function obstruction of the airways due to parenchymal destruction.

Defined by the presence of enlarged air spaces distal to the terminal bronchioles and the destruction of alveolar walls.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fibrosis

A

Fibrosis, also known as fibrotic scarring, is a pathological wound healing in which connective tissue replaces normal parenchymal tissue to the extent that it goes unchecked, leading to considerable tissue remodeling and the formation of permanent scar tissue.

Repeated injuries, chronic inflammation and repair are susceptible to fibrosis where an accidental excessive accumulation of extracellular matrix components, such as the collagen is produced by fibroblasts, leading to the formation of a permanent fibrotic scar.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Distal

A

Situated away from the center of the body or from the point of attachment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the factors that influence the development and severity of bronchitis and emphysema?

A
  1. Inhalation of noxious particles, such as toxins and carcinogens, and damage cells directly and induce deleterious reactive changes (e.g., hypertrophy of mucous glands and proliferation of goblet cells).
  2. Inflammation resulting from cell injury caused by toxic effects of inhaled agents.
  3. Proteases released from neutrophils are thought to have a central role in the emphysematous changes that accompany COPD.
  4. Microbial infection is often present but has a secondary role, chiefly by maintaining inflammation and exacerbating symptoms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Radial traction

A

The connective tissue that surrounds the airways of the lungs are called the parenchyma. This forms a sort of scaffold around the airways, keeping them open with a force known as “radial traction”. As inspiration takes place, the traction increases as the fibers that make the parenchyma are stretched.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Centriacinar (centrilobular) emphysema

A

The term centrilobular means that the disease occurs in the center of the functional units of the lungs, called the secondary pulmonary lobules.

Occurs with loss of the respiratory bronchioles in the proximal portion of the acinus, with sparing of distal alveoli. This pattern is most typical for smokers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Panacinar (panlobular) emphysema

A

Involves all lung fields, particularly the bases. Occurs with loss of all portions of the acinus from the respiratory bronchiole to the alveoli. This pattern is typical for alpha-1-antitrypsin deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the morphology of the bronchitic component of COPD?

A

It is marked by hyperemia of the bronchial and tracheal mucosa and excessive mucinous or mucopurulent secretions. The most characteristic microscopic feature is the enlargement of mucous-secreting glands. Variable numbers of inflammatory cells, including lymphocytes, macrophages, and neutrophils, are seen in the bronchial mucosa.

26
Q

Mucopurulent

A

Containing both mucus and pus.

27
Q

Morphology

A

The branch of biology that deals with the form of living organisms, and with relationships between their structures.

28
Q

Dyspnea

A

Difficult or labored breathing.

29
Q

What are the therapeutic approaches for COPD?

A
  • Smoking cessation programs to slow the decline in pulmonary function.
  • Vaccination against influenza and pneumococcus to prevent acute exacerbations due to infection.
  • Bronchodilators to counter inflammation-induced bronchospasm.
  • Anti-inflammatory agents, such as corticosteroids.
30
Q

What are the common causes of death in patients with COPD?

A

Heart failure, pneumonia, and pulmonary thromboembolism.

31
Q

Thromboembolism

A

Obstruction of a blood vessel by a blood clot that has become dislodged from another site in the circulation.

32
Q

Asthma

A

A chronic inflammatory disorder that causes episodic bronchospasm associated with airway obstruction.

33
Q

What are the factors contributing to the development of asthma?

A
  • A genetic predisposition to type I hypersensitivity (atopy).
  • Acute and chronic airway inflammation.
  • Bronchial hyper-responsiveness to a variety of stimuli.
34
Q

Atopy

A

Atopy is the tendency to produce an exaggerated immunoglobulin E (IgE) immune response to otherwise harmless substances in the environment. Allergic diseases are clinical manifestations of such inappropriate, atopic responses.

35
Q

What are the two subclassifications of asthma?

A
  1. Atopic: Evidence of allergen sensitization.

2. Nonatopic: No evidence of type I hypersensitivity.

36
Q

What triggers bronchospasm in asthma?

A

Allergens, respiratory infections (especially viral), airborne irritants (e.g., smoke, fumes), cold air, stress, and exercise.

37
Q

Atopic asthma

A

The most common type of asthma and is an example of an IgE-mediated type I hypersensitivity reaction. It usually begins in childhood.

Affected children develop type 2 helper T-cell (Th2) responses to various allergens present in dust, pollen, animal dander, or food.

Cytokines produced by Th2 T cells account for most of the features.

38
Q

Early-phase reaction (asthma)

A

Dominated by bronchoconstriction, mucous production, and vasodilation. Bronchoconstriction is triggered by mediators released by mast cells (histamine, prostaglandins, and leukotrienes) and also by reflex neural pathways.

39
Q

Late-phase reaction (asthma)

A

Attributed to chemokines (including eotaxin, a potent chemoattractant and activator of eosinophils) released by cells, such as epithelial cells, that promote recruitment of Th2 cells, eosinophils, and other leukocytes, amplifying an inflammatory reaction that is initiated by resident immune cells.

40
Q

Vasodilation

A

The dilatation of blood vessels, which decreases blood pressure.

41
Q

Nonatopic asthma

A

Not associated with allergen sensitization; a positive history of asthma is less common. Viral respiratory infections and inhaled air pollutants are common triggers, but exposures to cold air and exercise may also trigger an attack.

42
Q

Is mast mast cell activation common to both atopic and nonatopic asthma?

A

Yes

43
Q

Status asthmaticus

A

Acute severe asthma, formerly known as status asthmaticus, is defined as severe asthma unresponsive to repeated courses of beta-agonist therapy such as inhaled albuterol, levalbuterol, or subcutaneous epinephrine. It is a medical emergency that requires immediate recognition and treatment.

44
Q

Hypercapnia

A

Excessive carbon dioxide in the bloodstream, typically caused by inadequate respiration.

45
Q

Acidosis

A

An excessively acid condition of the body fluids or tissues.

46
Q

Hypertrophy

A

The enlargement of an organ or tissue from the increase in size of its cells.

47
Q

Hyperplasia

A

The enlargement of an organ or tissue caused by an increase in the reproduction rate of its cells, often as an initial stage in the development of cancer.

48
Q

Bronchiectasis

A

The permanent dilation of bronchi and bronchioles by destruction of smooth muscle and supporting elastic tissue; it typically results from or is associated with chronic necrotizing infections.

Pathogenesis: Either chronic obstruction or chronic infection may initiate the development of bronchiectasis.

Morphology: Usually affects the lower lobes, particularly air passages that are vertically aligned. When caused by tumors or foreign bodies, it may be localized to a single lung segment.

Clinical features: Characterized by a sever cough and expectoration of mucopurulent sputum, sometimes associated with dyspnea and hemoptysis.

Treatment: The use of antibiotics (to prevent and to treat disease flares), mucolytic agents (to help clear secretions), and surgery (for localized disease).

49
Q

Primary ciliary dyskinesia

A

Also called immotile cilia syndrome. Primary ciliary dyskinesia (PCD) is usually an autosomal recessive genetic condition in which the microscopic organelles (cilia) in the respiratory system have defective function. Ciliary dysfunction prevents the clearance of mucous from the lungs, paranasal sinuses and middle ears.

50
Q

Desquamation

A

Also called skin peeling. An unintended damage to and loss of the upper layer of skin.

51
Q

Hemoptysis

A

The coughing up of blood or blood-stained mucus from the bronchi, larynx, trachea, or lungs. In other words, it is the airway bleeding. This can occur with lung cancer, infections such as tuberculosis, bronchitis, or pneumonia, and certain cardiovascular conditions.

The primary danger comes from choking, rather than blood loss.

52
Q

Cor pulmonale

A

Cor pulmonale is a condition that causes the right side of the heart to fail. Long-term high blood pressure in the arteries of the lung and right ventricle of the heart can lead to cor pulmonale.

53
Q

What are the characteristics of restrictive lung diseases?

A

Bilateral pulmonary fibrosis and varying degrees of inflammation.

54
Q

What are the hallmarks of restrictive lung diseases?

A
  • Reduced compliance (stiff lungs).
  • Increased effort to breath (dyspnea).
  • Damage to alveolar epithelium and interstitial vasculature.
  • Abnormal ventilation-perfusion ratio.
  • Hypoxia.
  • Decreased forced vital capacity (FVC), which is a reflection of total lung volume.
55
Q

Idiopathic pulmonary fibrosis

A

A progressive disorder of unknown etiology characterized by patchy, progressive bilateral interstitial fibrosis that usually leads to “end-stage” lung and respiratory failure.

Idiopathic pulmonary fibrosis is a diagnosis of exclusing.

Pathogenesis: The interstitial fibrosis is believed to result from repeated injury and defective repair of alveolar epithelium.

Clinical features: More common in males and is a disease of aging, virtually never occurring before 50 years of age. It presents with a unproductive cough and progressive dyspnea. On physical examination, characteristic “dry” or “Velcro-like” crackles are heard during inspiration.

Treatment: Antifibrotic therapies have produced positive outcomes in clinical trials and are approved for use, but the overall prognosis is poor. Survival is only 3 to 5 years after diagnosis and lung transplantation is the only definitive treatment.

56
Q

Etiology

A

The cause, set of causes, or manner of causation of a disease or condition.

57
Q

Pathogenesis

A

The process by which a disease or disorder develops. It can include factors which contribute not only to the onset of the disease or disorder, but also to its progression and maintenance.

58
Q

Honeycomb fibrosis

A

Honeycombing or “honeycomb lung” is the radiological appearance seen with widespread fibrosis and is defined by the presence of small cystic spaces with irregularly thickened walls composed of fibrous tissue.

59
Q

Differential diagnosis

A

A differential diagnosis (abbreviated DDx) is a method of analysis of a patient’s history and physical examination to arrive at the correct diagnosis. It involves distinguishing a particular disease or condition from others that present with similar clinical features.

60
Q

Indication

A

A valid reason to use a certain test, medication, procedure, or surgery.

61
Q

Contraindication

A

A condition that serves as a reason to not take a certain medical treatment due to the harm that it would cause the patient.